LLY.SW
Price:
$955
Market Cap:
$1.09T
Eli Lilly and Company is a global pharmaceutical enterprise engaged in the discovery, development, and commercialization of human pharmaceutical products. Its diverse portfolio provides treatments across multiple therapeutic areas. In the field of diabetes care, the company offers a comprehensive range of insulins, such as Basaglar, various formulations of Humalog (including U-100, U-200, Mix 75/25, and Mix 50/50), insulin lispro, insulin lispro protamine, and insulin lispro mix 75/25. Additionally, its Humulin line features Humulin 70/30, Humulin N, Humulin R, and Humulin U-500. For the management of type 2 diabetes, key medications include Jardiance, Trajenta, and Trulicity. Its oncology d...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1998-07-17
Stock Exchange
SIX
Ticker
LLY.SW
According to Eli Lilly and Company’s latest financial reports and current stock price. The company's current Enterprise Value is 1.13T. This represents a change of 22.45% compared to the average of 923.70B of the last 4 quarters.
The mean historical Enterprise Value of Eli Lilly and Company over the last ten years is 352.93B. The current 1.13T Enterprise Value has changed 31.95% with respect to the historical average. Over the past ten years (40 quarters), LLY.SW's Enterprise Value was at its highest in in the June 2026 quarter at 1.12T. The Enterprise Value was at its lowest in in the December 2016 quarter at 86.69B.
Average
352.93B
Median
225.47B
Minimum
86.69B
Maximum
1.00T
Discovering the peaks and valleys of Eli Lilly and Company Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 58.49%
Maximum Annual Enterprise Value = 1.00T
Minimum Annual Increase = -11.03%
Minimum Annual Enterprise Value = 86.69B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.00T | 37.86% |
| 2024 | 725.64B | 32.74% |
| 2023 | 546.67B | 51.10% |
| 2022 | 361.79B | 30.85% |
| 2021 | 276.48B | 58.49% |
| 2020 | 174.45B | 25.22% |
| 2019 | 139.31B | 14.28% |
| 2018 | 121.91B | 27.03% |
| 2017 | 95.96B | 10.70% |
| 2016 | 86.69B | -11.03% |
The current Enterprise Value of Eli Lilly and Company (LLY.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
757.57B
5-year avg
582.20B
10-year avg
352.93B
Eli Lilly and Company’s Enterprise Value is greater than Roche Holding AG (310.37B), greater than Novartis AG (307.49B), greater than Cosmo Pharmaceuticals N.V. (969.87M), greater than Abbott Laboratories (204.95B), greater than Lonza Group AG (41.79B), greater than Ypsomed Holding AG (4.77B), greater than Siegfried Holding AG (4.03B), greater than Ascom Holding AG (168.74M), greater than Alcon Inc. (35.66B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 310.37B | $256.55B | |
| 307.49B | $218.77B | |
| 969.87M | $1.01B | |
| 204.95B | $125.45B | |
| 41.79B | $38.11B | |
| 4.77B | $4.54B | |
| 4.03B | $3.20B | |
| 168.74M | $194.04M | |
| 35.66B | $26.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eli Lilly and Company using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eli Lilly and Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Eli Lilly and Company's Enterprise Value?
What is the highest Enterprise Value for Eli Lilly and Company (LLY.SW)?
What is the 3-year average Enterprise Value for Eli Lilly and Company (LLY.SW)?
What is the 5-year average Enterprise Value for Eli Lilly and Company (LLY.SW)?
How does the current Enterprise Value for Eli Lilly and Company (LLY.SW) compare to its historical average?